$ICPT Intercept to Present at the 38th Annual J.P. Morgan Healthcare Conference: In 2019 we saw a number of mega-deals, including the $63 billion AbbVie-Allergan merger and the $11.4 billion acquisition of Array BioPharma by Pfizer. On the opening day of the meeting, attendees woke up to news that Eli Lilly and Company had offered $8 billion for Loxo Oncology. In the run-up to the J.P. Morgan conference, Bristol-Myers Squibb took the industry by surprise by unveiling the $74 billion acquisition of Celgene. J.P. Morgan Healthcare conference caters to both the earliest stage startups, those seeking grants, seed and angel capital, as well as big pharma companies searching for the next monstrous acquisition deal. biospace.com/article/releas...
  • 5